Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04117945
Title Regorafenib, With Cetuximab or Panitumumab, for the Treatment of Unresectable, Locally Advanced, or Metastatic Colorectal Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Academic and Community Cancer Research United
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic in Arizona Scottsdale Arizona 85259 United States Details
USC / Norris Comprehensive Cancer Center Los Angeles California 90033 United States Details
MedStar Georgetown University Hospital Washington District of Columbia 20007 United States Details
Mayo Clinic in Florida Jacksonville Florida 32224 United States Details
Emory University Hospital/Winship Cancer Institute Atlanta Georgia 30322 United States Details
University of Chicago Comprehensive Cancer Center Chicago Illinois 60637 United States Details
University of Iowa/Holden Comprehensive Cancer Center Iowa City Iowa 52242 United States Details
Siouxland Regional Cancer Center Sioux City Iowa 51101 United States Details
Cancer Center of Kansas Wichita Kansas 67214 United States Details
Mayo Clinic Rochester Minnesota 55905 United States Details
University of Nebraska Medical Center Omaha Nebraska 68198 United States Details
Duke University Medical Center Durham North Carolina 27710 United States Details
Toledo Clinic Cancer Center Toledo Ohio 43623 United States Details
Allegheny General Hospital Pittsburgh Pennsylvania 15212 United States Details
Aurora Cancer Care-Milwaukee West Wauwatosa Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field